These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9200340)

  • 1. Prophylaxis of venous thromboembolism in stroke patients.
    Turpie AG
    Semin Thromb Hemost; 1997; 23(2):155-7. PubMed ID: 9200340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract]   [Full Text] [Related]  

  • 3. Orgaran in the prevention of deep vein thrombosis in stroke patients.
    Turpie AG
    Haemostasis; 1992; 22(2):92-8. PubMed ID: 1379969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
    Counsell C; Sandercock P
    Stroke; 2002 Jul; 33(7):1925-6. PubMed ID: 12105377
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.
    Wade WE
    Am J Orthop (Belle Mead NJ); 1999 Apr; 28(4):229-31. PubMed ID: 10220094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danaparoid: a review of its use in thromboembolic and coagulation disorders.
    Ibbotson T; Perry CM
    Drugs; 2002; 62(15):2283-314. PubMed ID: 12381232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danaparoid in the prevention of thromboembolic complications.
    Skoutakis VA
    Ann Pharmacother; 1997; 31(7-8):876-87. PubMed ID: 9220051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease.
    Bergqvist D
    Aust N Z J Surg; 1998 Jul; 68(7):463-8. PubMed ID: 9669358
    [No Abstract]   [Full Text] [Related]  

  • 9. Danaparoid is not a low-molecular-weight heparin.
    Nicholson CD; Meuleman DG; Magnani HN; Egberts JF; Leibowitz DA; Spinler SA; Cziraky MJ
    Am J Hosp Pharm; 1994 Aug; 51(16):2049-50. PubMed ID: 7526686
    [No Abstract]   [Full Text] [Related]  

  • 10. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature.
    Wade WE
    Thromb Res; 1998 Feb; 89(4):199-202. PubMed ID: 9651147
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparinoids Danaparoid and Sulodexide as clinically used drugs.
    Dou H; Song A; Jia S; Zhang L
    Prog Mol Biol Transl Sci; 2019; 163():55-74. PubMed ID: 31030761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparins and heparinoids.
    Eikelboom JW; Hankey GJ
    Med J Aust; 2002 Oct; 177(7):379-83. PubMed ID: 12358583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of venous thromboembolism after treatment with unfractionated heparin.
    Sutton SK
    Ann Intern Med; 1996 Mar; 124(5):532. PubMed ID: 8602716
    [No Abstract]   [Full Text] [Related]  

  • 15. Ardeparin and danaparoid.
    Dimens Crit Care Nurs; 2000; 19(4):13-4. PubMed ID: 11998151
    [No Abstract]   [Full Text] [Related]  

  • 16. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
    Turpie AG; Gent M; Côte R; Levine MN; Ginsberg JS; Powers PJ; Leclerc J; Geerts W; Jay R; Neemeh J
    Ann Intern Med; 1992 Sep; 117(5):353-7. PubMed ID: 1503326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
    Boneu B
    Haemostasis; 1996 Oct; 26 Suppl 4():368-78. PubMed ID: 8979141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heparin-induced thrombopenia and thrombosis].
    Stöckli TC; Walther A; Görres G; Ritz R; Marbet GA
    Schweiz Med Wochenschr; 1996 Mar; 126(12):483-8. PubMed ID: 8650513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran. Summary.
    ten Cate JW
    Haemostasis; 1992; 22(2):109-11. PubMed ID: 1379964
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke.
    Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Magnani HN; Hull RD; Gent M
    Lancet; 1987 Mar; 1(8532):523-6. PubMed ID: 2434815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.